Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection.
Tatsuo HataMasamichi MizumaFuyuhiko MotoiHideo OhtsukaKei NakagawaTakanori MorikawaMichiaki UnnoPublished in: Journal of hepato-biliary-pancreatic sciences (2022)
Postoperative ctDNA, as a minimal residual marker, can be useful for predicting the risk of recurrence in patients with PDAC even after curative resection.